O Shaughnessy Asset Management LLC Sells 1,035 Shares of Bruker Co. (NASDAQ:BRKR)

O Shaughnessy Asset Management LLC decreased its position in shares of Bruker Co. (NASDAQ:BRKR) by 17.3% in the 4th quarter, Holdings Channel reports. The firm owned 4,941 shares of the medical research company’s stock after selling 1,035 shares during the quarter. O Shaughnessy Asset Management LLC’s holdings in Bruker were worth $290,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of BRKR. Eagle Bay Advisors LLC lifted its holdings in Bruker by 2,324.1% in the fourth quarter. Eagle Bay Advisors LLC now owns 703 shares of the medical research company’s stock valued at $41,000 after buying an additional 674 shares during the period. UMB Bank n.a. raised its position in shares of Bruker by 37.5% in the 4th quarter. UMB Bank n.a. now owns 909 shares of the medical research company’s stock worth $53,000 after acquiring an additional 248 shares in the last quarter. GAMMA Investing LLC lifted its stake in shares of Bruker by 47.5% in the 4th quarter. GAMMA Investing LLC now owns 1,279 shares of the medical research company’s stock valued at $75,000 after purchasing an additional 412 shares during the period. EverSource Wealth Advisors LLC boosted its position in shares of Bruker by 41.5% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,330 shares of the medical research company’s stock valued at $78,000 after purchasing an additional 390 shares in the last quarter. Finally, Blue Trust Inc. grew its stake in Bruker by 13.5% during the fourth quarter. Blue Trust Inc. now owns 2,164 shares of the medical research company’s stock worth $127,000 after purchasing an additional 257 shares during the period. 79.52% of the stock is owned by institutional investors.

Bruker Price Performance

Shares of NASDAQ BRKR opened at $38.76 on Friday. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.77 and a current ratio of 1.60. The firm’s 50-day simple moving average is $46.16 and its 200 day simple moving average is $54.75. The stock has a market cap of $5.88 billion, a price-to-earnings ratio of 51.00, a PEG ratio of 2.16 and a beta of 1.18. Bruker Co. has a fifty-two week low of $34.10 and a fifty-two week high of $90.03.

Bruker (NASDAQ:BRKR) last announced its earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%. As a group, research analysts anticipate that Bruker Co. will post 2.69 earnings per share for the current fiscal year.

Bruker Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, March 28th. Investors of record on Monday, March 17th were given a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.52%. The ex-dividend date was Monday, March 17th. Bruker’s payout ratio is currently 26.32%.

Analysts Set New Price Targets

Several equities analysts have issued reports on the company. Barclays dropped their price target on Bruker from $60.00 to $50.00 and set an “overweight” rating on the stock in a research note on Thursday. Guggenheim reissued a “buy” rating on shares of Bruker in a research note on Monday, February 24th. Citigroup decreased their price target on shares of Bruker from $75.00 to $50.00 and set a “buy” rating for the company in a research note on Monday, April 7th. Finally, Stifel Nicolaus cut their price objective on shares of Bruker from $70.00 to $57.00 and set a “hold” rating on the stock in a research report on Friday, February 14th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $66.50.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.